Unlocking the Power of Cerebroprotein Hydrolysate for Injection
- Farbe Firma
- Apr 19, 2024
- 1 min read
Updated: Jun 23, 2024
Cerebroprotein Hydrolysate (CH), a remarkable neurotrophic supplement, has been making waves in the medical world. As a manufacturer of this groundbreaking product, Farbe Firma Pvt Ltd is at the forefront of innovation. Let’s delve into the science behind CH and explore how it can enhance neurological health.
What Is Cerebroprotein Hydrolysate?
CH is an aqueous solution derived from enzymatically hydrolyzed animal brain tissue. It contains a mixture of various amino acids and low-molecular-weight peptides.
The total nitrogen content in CH exceeds 120 mg/g, making it a potent neuroprotective agent.
Within its composition, you’ll find 16 essential amino acids and small molecule polypeptides (<10,000 Da).
Notably, CH contains nerve growth factors with pharmacodynamic characteristics similar to endogenous neurotrophic factors.
Neuroprotective Effects
Reducing Inflammation and Apoptosis:
CH has been shown to reduce the inflammatory response, apoptosis, and cerebral edema.
Activation of BDNF Pathway:
BDNF plays a crucial role in neuronal recovery after stroke.
CH may up-regulate BDNF expression, leading to improved neurobehavioral function1.
MEK/ERK1/2 Signaling Pathway:
Clinical Applications
Stroke Recovery: CH aids in post-stroke recovery by supporting neuronal repair and minimizing damage.
Alzheimer’s Disease: CH has demonstrated cognitive benefits in AD patients.
Administration Routes: CH can be administered orally, intramuscularly, or intravenously, depending on the formulation and condition being treated.
Farbe Firma Pvt Ltd’s commitment to advancing neurological health through Cerebroprotein Hydrolysate is commendable. As more research unfolds, CH’s potential continues to captivate the medical community.
Comentários